Pictet-Biotech-HR EUR

To increase the value of your investment while seeking to achieve a positive social impact. Reference Index MSCI AC World (USD), an index that does not take into account environmental, social and governance (ESG) factors. Used for risk monitoring, performance objective and performance measurement. Portfolio Assets The Fund invests at least two-thirds of its net assets in equities of companies operating in the medical biotechnology sector. The Fund may invest worldwide, including in emerging markets and Mainland China, although most of investments are concentrated in the United States of America and Western Europe. Derivatives and Structured Products The Fund may use derivatives to reduce various risks (hedging) and for efficient portfolio management, and may use structured products to gain exposure to portfolio assets. Fund Currency USD Investment Process In actively managing the Fund, the Investment Manager uses a combination of market and fundamental company analysis to select securities that it believes offer favourable growth prospects at a reasonable price.The Investment Manager considers ESG factors a core element of its strategy by seeking to invest mainly in economic activities that contribute to a social objective whilst avoiding activities that adversely affect society or the environment. Voting rights are methodically exercised and there may be engagement with companies to positively influence ESG practices. For further information, please refer to our exclusion framework in the Responsible Investment policy*, SFDR product category Article 9. The portfolio composition is not constrained relative to the benchmark, so the similarity of the Fund's performance to that of the benchmark may vary.

PIR compliant

No

PEA compliant

No

PEA-PME compliant

No